|
|
News for Healthier Living
Engineered Gut Bacteria Therapy Emerges as Scalable Potential Alternative to Fecal Microbiota Transplants Following Clinical Trial
Researchers at the Icahn School of Medicine at Mount Sinai have developed a new manufacturing platform for producing targeted mixtures of beneficial gut bacteria, an approach that could help expand access to microbiome-based therapies for patients with recurrent Clostridioides difficile (C. difficile) infection. Their findings were published in the June 2 issue of Nature Medicine [10.1038/s41591-026-04442-2].
Recurrent C. difficile infection is a serious and often debilitating condition that can occur after antibiotic treatment disrupts the natural balance of bacteria in the gut. Although fecal microbiota transplants (FMT)--a treatment that transfers stool from healthy donors to restore gut bacteria in patients with severe or recurrent infections--have proven effective for many patients, more standardized and scalable therapeutic options are needed.
June 2, 2026
June 2 2026June 1 2026 - Nursing Home Staffing Declined in States That Protected Facilities From COVID-19 Malpractice Lawsuits
- Mount Sinai Researchers Uncover a Substantial Genetic Component to Postpartum Psychosis, Advancing Understanding of Severe Maternal Mental Illness
- Blood Test Shows Promise for Detecting Testicular Cancer When Standard Markers Miss
- UChicago renewed to host NRG Oncology Statistics and Data Management Center for National Cancer Institute
- Clinical Trial Shows Novel Prostate Cancer Treatment Can Reduce Risk of Disease Progression by Half
- Deep Brain Stimulation Remodels Brain Wiring and Alters Functional Changes to Brain-Wide Networks, Landmark Depression Study Reveals
- 7 Trends Reshaping Pediatric Hip Dysplasia Care
- Lab Research Suggests Magnetic Particle Imaging May Help Researchers Find More Effective Ways to Deliver Cell Therapies
- Split Personalities: Researchers Who Bridge Disciplines
- From Fundamental Biology to Treatments for Disease, Stem Cells are Engines of Discovery
- Joan A. Steitz: The 'Queen of RNA' and Her Scientific Feats
- Many Adults with a Normal BMI May Still Have Obesity-Related Health Risks
- Body Mass Index Found to Drastically Underestimate Obesity Levels in the United States
- Your Surprise Medical Bill May Be Gone — But Your Premiums Could Still Spike
- Short-Term Fasting Could Boost Chemo Response in Ovarian Cancer, Study Suggests
- New Analysis Confirms Benefits of Childhood Flu Vaccines
- Hormone Therapy Use for Menopause Declines Despite Proven Benefits, Study Finds
- Powering Every Step: $2M to Develop Knee Exoskeletons for Arthritis Relief, Mobility
- JMIR Report: Digital Platforms and Policy Shifts Reshape GLP-1 Affordability
- Researchers Create First-of-Its-Kind Index of Evolving Policy Landscape Around Health Care AI
- Perfectionism Among College Students Reaches Record High, Fueling Anxiety
- Workout Habits May Protect Against Inherited Heart Problems
- New Survey Results Explore the Complexity of Marijuana Use and Sleep
- Childhood Lying Is Normal and Rarely Signals Behavioral Concerns, Study Says
- Weed Linked To Higher Testosterone Levels In Young Men
- After Her Bout of Amnesia, A $59,000 Billing Dispute Wouldn't Go Away
- Most People Over 50 Have LGBTQ+ Friends or Family, but LGBTQ+ People Over 50 Face More Aging-Related Challenges, Poll Finds
- ASCO: Targeted Therapy Combo Nearly Doubles Time Without Disease Progression for Patients with Advanced Colorectal Cancer
- Virtual Eyes in the Operating Room: AI Detects Surgical Safety Landmark Across Hospitals
- Post-Discharge Antibiotics May Offer Limited Benefit After Pediatric Appendicitis
- Teamwork, Technology Streamline Feeding Tube Placement
- Tomorrow at ASCO 2026: Roswell Park Researchers Spotlight New Insights in Breast Cancer, Myeloma Care and AI
- Study: New Drug Could Dramatically Increase Pancreatic Cancer Survival
- Investigational Targeted Therapy Doubles Survival in Metastatic Pancreatic Cancer
- Targeted Therapy Reduces Risk of Lung Cancer Recurrence by 83% in Rare Genetic Subtype
- Precigen Presents New Long-Term Durability Data for PAPZIMEOS, Recently Granted Seven-Year Market Exclusivity, Demonstrating Complete Responses Beyond 4 Years
- June 2026 Issue of Neurosurgical Focus: "Craniopharyngioma: Contemporary Management"
May 31 2026May 30 2026May 29 2026May 28 2026May 27 2026May 26 2026May 25 2026May 22 2026May 21 2026May 20 2026 - Cedars-Sinai Research Identifies Drivers of Liver Disease
- Study Identifies New Marker to Find Patients with Advanced Prostate Cancer More Likely to Benefit From Combination Immunotherapy
- New Exhibit Explores Far-Reaching Impact of an Ancient Eye Disease
- The Neural Basis of Thought Symbols Identified for the First Time
- Can Wastewater Surveillance Work Without Sewers?
- First National Study of Home Care Safety for Children with Medical Complexity
- Tumor Microenvironment Features May Predict Immunotherapy Response in Rare Cancers
- Genetically Reengineered Bacteria Targets Cancerous Tumors
- Novel Blood Test Detects Rejection After Lung Transplant
- How Tetracyclines Work: New Study Redefines Mechanism-of-Action
- FL118 Granted FDA Rare Pediatric Disease Designation and Orphan Drug Designation for Osteosarcoma
- In Middle-Aged and Older Adults, Migraine with Aura Associated with Higher Stroke Risk
- Quitting Smoking Associated with Lower Dementia Risk
- Rollback of PFAS Drinking Water Standards Raises Safety Fears
- Positional Therapy Offers Lasting Benefits for Most Positional OSA Patients
- Early CPAP Struggles Don't Predict Treatment Failure, Study Finds
- Your Handwriting Could Be a Window Into Your Aging Brain
- Nearly 10% of Surgeons are Leaving the Profession Within 8 Years
- Pilot Trial Suggests Anti-Inflammatory Drug Could Help Difficult-to-Treat Depression
- No Meaningful Health Impacts From Exposure to Wind Turbines
- Cytokine-Armored CAR-T Cell Therapy Helps Eliminate Aggressive Brain Tumors in Preclinical Study
- Study Suggests Novel Way to Protect Aging Brains After Surgery
- Teens Turning To Creatine, Not Steroids, For 'Looksmaxxing'
- Once-A-Day Pill Effective In Treating Sleep Apnea Without CPAP, Clinical Trial Says
- Could K17 be a Key Treatment Target for Pancreatic Cancer?
- Endocrine Society, Keystone Symposia to Host First Joint Conference in October
- How Do Caffeine, Alcohol, Weed, Nicotine Affect MS Symptoms?
- BGSU Scientists Make Groundbreaking Discovery - and Find a Possible New Ally - in the Opioid Crisis
- Childhood Trauma Tied to Higher Obesity Risk, But One Caring Adult Can Make A Difference
- Eroding ACA Enrollment Portends Higher Insurance Rates
- Ozone Pollution Limits Lung Benefits of Exercise in Children
- Squeezed and Sped Up: Viscous Stress Primes Glioblastoma Cells for Invasion
- Study: Hospital Wastewater Reveals Drug-Resistant Fungus Strains Months Before Patients Show Symptoms
- Saliva Could Flag One of SA's Deadliest and Baffling Cancers Sooner
- AI Foundation Models Offer a New Vision for Eye Care
May 19 2026
|
|
|
|
|